Osteoporotic hip fracture is the most severe kind of fragility fracture that carries high chances of disability and mortality. Recent advances in surgical treatment have shed new light in the management of these fractures. Nevertheless, the poor bone quality sometimes renders the treatment unsuccessful and there remains a definite complication rate in its treatment. Up till now, there has been a continuous effort in improving the currently used implants and surgical techniques, ranging from joint replacements to various forms of internal fixation. To complicate the issue even more, it was found recently that some fractures are related to the antiosteoporotic medications that the patients take as prophylaxis to osteoporotic fractures. As a result, there is a need for understanding the factors determining successful treatment in order to provide better care to these patients.

We invite investigators to contribute original research articles that will enhance development of novel treatment modalities as well as further understanding of the treatment strategies and the evaluation of outcomes. Potential topics include, but are not limited to:

• Recent advances in surgical techniques including augmentation of fixation
• Clinical trials offering evidence in the best practice
• Development of new concepts of fracture fixation and fracture prevention
• Atypical femoral fractures associated with antiosteoporotic drugs and related treatment

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.tswj.com/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.tswj.com/submit/orthopedics/hip/ according to the following timetable: